Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKolesnichenko, P. D.-
dc.contributor.authorGudyrev, O. S.-
dc.contributor.authorZhuchenko, M. A.-
dc.contributor.authorZhernakova, N. I.-
dc.contributor.authorFaitelson, A. V.-
dc.identifier.citationEvaluation of carbamylated darbepoetin acute toxicity / P.D. Kolesnichenko [et al.] // International Journal of Research in Pharmaceutical Sciences. - 2018. - Vol.9, №3.-P. 725-730. - DOI: - Refer.: p.
dc.description.abstractCarbamylated darbepoetin is a promising pharmacological agent with universal cytoprotective activity. To assess the acute toxicity, the drug was administered to white laboratory mice and white laboratory rats subcutaneously (from 1000 to 5000 μg / kg) and intravenously (500 to 2500 μg / kg). There was no lethality and no phenotypic changes (including from the red blood sprout) in both species of animals. The study showed that the drug carbamylated darbepoetin (Pharmapark, Russia) belongs to the IV class of low-toxic drugsru
dc.subjectpharmacological agentsru
dc.subjectcarbamylated darbepoetinru
dc.subjectacute toxicityru
dc.titleEvaluation of carbamylated darbepoetin acute toxicityru
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Kolesnichenko_Evaluation.pdf9.85 MBAdobe PDFView/Open
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.